Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Actinium Pharmaceuticals, Inc. has filed 495 SEC EDGAR filings since 05 Feb 2007

SEC filing history

Showing 176-200 of 469 matching filings.

Per page
25
Current page
8
8-K File 001-36374

CURRENT REPORT

Filing date
28 Dec 2018
Reporting date
28 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
26 Dec 2018
Reporting date
21 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
21 Dec 2018
Reporting date
18 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Nov 2018
Reporting date
19 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36374

PRELIMINARY PROXY STATEMENT

Filing date
16 Nov 2018
Reporting date
18 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
09 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
PRE 14A File 001-36374

PRELIMINARY PROXY STATEMENT

Filing date
30 Oct 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
18 Oct 2018
Reporting date
18 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-216748

PROSPECTUS SUPPLEMENT

Filing date
18 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
15 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
09 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
15 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
10 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
01 May 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
01 May 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .